As we complete our first year, we are pleased to share how the project is developing a new approach to understanding schizophrenia. This condition is complex and influenced by many biological and environmental factors. VOLABIOS brings together experts across Europe to study these different aspects using complementary technologies.
During 2025, our partners focused on building the project’s core tools and infrastructure. This includes advanced genetic and molecular analysis, innovative breath and skin-sensing technologies, and a secure digital platform that enables researchers to combine and analyze different types of health data.
In the coming year, the project will transition from planning to active research. Clinical studies and stakeholder engagement activities will start across several sites, helping ensure that the knowledge generated by VOLABIOS can ultimately support earlier detection and better care for people affected by schizophrenia.
In this issue:
- Multi-Omics Technology — FIRALIS
- VOCs Analysis — SmartNanoSense
- Data Infrastructure — EXUS AI Labs
- Biobank — FIRALIS
- Machine Learning Models — CERTH
- Legal Framework — TIMELEX
- Living Labs — LSMU